Furthermore, proteomic analysis revealed upregulation of ceramide synthase 5 and S1P lyase in SLE patients, suggesting that increased ceramide levels and decreased S1P might result from enhanced ceramide biosynthesis or S1P degradation [17]. This evidence concerns the gene MBTPS1 and systemic lupus erythematosus.